This book provides general information on breast cancer management and considers all new methods of diagnosis and therapy. It focuses on nuclear medicine modalities by comparing their results with other diagnostic and therapeutic approaches. Coverage provides readers with up-to-date knowledge in breast cancer as well as information on the advances in the field of diagnosis. It also details data on the development of some new modalities and provides a general overview of the available tools for breast cancer treatment. The text is essential not only for nuclear medicine physicians but also for oncologists, radiologists, surgeons, and practitioners who wish to learn about the contribution of modern nuclear medicine to general breast cancer management strategies.

Histological Classification of Breast Cancer

Biomarkers for Breast Cancer: Towards the Proposition of Clinically Relevant Tools
Circulating Tumour Markers in Breast Cancer
Axillary Lymph Node Status Evaluation in Breast Cancer Patients: Role of SPECT and Pinhole SPECT with Cationic Lipophilic Radiotracers
Breast Imaging with Scintimammography
99mTc-MIBI in the Evaluation of Breast Cancer Biology
Sentinel Node Detection in Pre-Operative Axillary Staging
State of the Art of Current Modalities for the Diagnosis of Breast Lesions
New Trends of MRI in Breast Cancer Diagnosis
PET Imaging of Breast Cancer Molecular Biomarkers
The Role of FDG-PET for Axillary Lymph Node Staging in Primary Breast Cancer
Measuring Response to Chemotherapy in Locally Advanced Breast Cancer: Methodological Considerations
FDG-PET in Monitoring Therapy of Breast Cancer
FDG-PET and Tumour Marker Tests for the Diagnosis of Breast Cancer
Advantages and Limitations of FDG PET 16 in the Follow-Up of Breast Cancer
PET/CT and Breast Cancer
Current Role of Bone Scan with Phosphonates in the Follow-Up of Breast Cancer
Progress in the Treatment of Early and Advanced Breast Cancer
186Re-HEDP for Metastatic Bone Pain in Breast Cancer Patients
153Sm-EDTM for Bone Pain Treatment in Skeletal Metastases
The Choice of the Correct Imaging Modality in Breast Cancer Management.